- $6.24m
- $8.87m
- $10.85m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.63 | ||
| Price to Tang. Book | 1.5 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.58 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -144.69% | ||
| Return on Equity | -654.61% | ||
| Operating Margin | -164.02% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 82.84 | 84.13 | 14.51 | 12.74 | 10.85 | 15.96 | 24.78 | -20.93% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ontrak, Inc. is a value-based behavioral healthcare company that identifies and engages people with unmet health needs using its advanced engagement system to improve clinical outcomes. The Company identifies, engages, and delivers care to the vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. Through its Advanced Engagement System, it engages individuals with anxiety, depression, substance use disorders and chronic disease by delivering personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. It integrates AI, predictive analytics, comprehensive clinical and claims data, patient-generated information, and digital interfaces with care coach engagements to deliver improved member health and better healthcare system utilization.
Directors
- Terren Peizer CHM (62)
- Jonathan Mayhew CEO (57)
- Brandon LaVerne CFO (49)
- Arik Hill CIO (51)
- Robert Newton GCN (55)
- Robert Accordino OTH (40)
- Carol Murdock OTH
- Mary Osborne OTH (60)
- Richard Berman IND (76)
- Gustavo Giraldo IND (49)
- Robert Rebak IND (53)
- Diane Seloff IND (57)
- Michael Sherman IND (62)
- Edward Zecchini IND (60)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 29th, 2003
- Public Since
- September 27th, 2002
- No. of Shareholders
- 50
- No. of Employees
- 104
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 4,217,848
- Address
- 333 S. E. 2ND AVENUE, SUITE 2000, MIAMI, 33131
- Web
- https://ontrakhealth.com/
- Phone
- +1 3104444300
- Auditors
- EisnerAmper LLP
Upcoming Events for OTRK
Q2 2025 Ontrak Inc Earnings Release
Ontrak Inc Annual Shareholders Meeting
Similar to OTRK
ADVANCED BIOMED
NASDAQ Capital Market
IMEI Technology Health
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
Basel Medical
NASDAQ Capital Market
FAQ
What is the Ontrak share price?
As of Today at 22:26 UTC, shares in Ontrak are trading at $1.48. This share price information is delayed by 15 minutes.
How has the Ontrak share price performed this year?
Shares in Ontrak last closed at $1.48 and the price had moved by -70.37% over the past 365 days. In terms of relative price strength the Ontrak share price has underperformed the S&P500 Index by -72.65% over the past year.
What are the analyst and broker recommendations for Ontrak?
The overall consensus recommendation for Ontrak is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Ontrak dividend yield?
Ontrak does not currently pay a dividend.
Does Ontrak pay a dividend?
Ontrak does not currently pay a dividend.
When does Ontrak next pay dividends?
Ontrak does not currently pay a dividend.
How do I buy Ontrak shares?
To buy shares in Ontrak you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Ontrak?
As of the previous close price of $1.48, shares in Ontrak had a market capitalisation of $6.24m.
Where are Ontrak shares listed?
Here are the trading details for Ontrak:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: OTRK
What kind of share is Ontrak?
Based on an overall assessment of its quality, value and momentum Ontrak is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Ontrak share price forecast for 2025?
The analyst consensus target price for shares in Ontrak is $4.00. That is 170.27% above the last closing price of $1.48.
Analysts covering Ontrak currently have a consensus Earnings Per Share (EPS) forecast of -$4.05 for the next financial year.
Find out moreWhat is the trend in the Ontrak share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ontrak. Over the past six months, its share price has underperformed the S&P500 Index by -20.82%.
As of the last closing price of $1.48, shares in Ontrak were trading -32.17% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Ontrak PE Ratio?
The Ontrak PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Ontrak?
Ontrak's management team is headed by:
- Terren Peizer - CHM
- Jonathan Mayhew - CEO
- Brandon LaVerne - CFO
- Arik Hill - CIO
- Robert Newton - GCN
- Robert Accordino - OTH
- Carol Murdock - OTH
- Mary Osborne - OTH
- Richard Berman - IND
- Gustavo Giraldo - IND
- Robert Rebak - IND
- Diane Seloff - IND
- Michael Sherman - IND
- Edward Zecchini - IND